NDC 0409-2012 – Buprenorphine Hydrochloride

Buprenorphine Hydrochloride .3 mg/mL · Injection, Solution · Intramuscular, Intravenous

Human Prescription Drug DEA schedule CIII 2 recalls

Product NDC0409-2012

Product details

Brand name
Buprenorphine Hydrochloride
Generic name
Buprenorphine Hydrochloride
Labeler
Hospira, Inc.
Dosage form
Injection, Solution
Route
Intramuscular, Intravenous
Marketing category
ANDA · ANDA074137
Marketed since
June 14, 2005
Listing expires
December 31, 2026
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine Hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
0409-2012-3210 CARTRIDGE in 1 CARTON (0409-2012-32) / 1 mL in 1 CARTRIDGE (0409-2012-03)Jun 14, 2005

Recalls mentioning this NDC

Other Buprenorphine Hydrochloride products